Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-20

Clinical Trial Update: A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50 [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Amneal's Fluticasone Propionate/Salmeterol Inhalation Powder to Advair Discus 100/50 for asthma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advair Discus 100/50 (fluticasone propionate/salmeterol inhalation powder)
  • Fluticasone Propionate/Salmeterol Inhalation Powder (fluticasone propionate/salmeterol inhalation powder)

Snippet

Sponsor: Amneal Ireland Limited | Conditions: Asthma | Phase 3 | Status: UNKNOWN